| Feed Actions |
|
 |
| Subscribe |
|
|
|
|
|
|
|
|
|
|
|
| You are here: 1800 RssFeeds Home >> Science RSS Feeds >> Biology RSS Feeds >> LifeSciencesWorld |
Lifesciencesworld.com - LifeSciencesWorld @ 1800 RSSFeeds.Com |
| Site URL: | http://www.lifesciencesworld.com/ |
| Feed Description: | LifeSciencesWorld is the latest stuff from your online resource for biotechnology, pharmaceutical, medical devices and life sciences industries. This xml give biotechnology related articles, biotechnology industry news, searchable database listings for companies, universities and events. |
| Feed URL: | http://www.lifesciencesworld.com/rss/lifesciencesworld.rss
 |
| Site Title: | LifeSciencesWorld |
| Site Description: | "LifeSciencesWorld is your online resource for biotechnology, pharmaceutical, medical devices and life sciences industries." |
Lifesciencesworld RSS Details |
|
USAID Increases Assistance For Zimbabwe Cholera Outbreak [NEWS] WASHINGTON, Dec. 4 — The U.S. Government, through the U.S. Agency for International Development (USAID), is providing an additional $600,000 to help combat the cholera outbreak in Zimbabwe. This assistance is in addition to the $4 million water, sanitation, and hygiene emergency program USAID is already implementing in Zimbabwe. “Before cholera was widespread,... |
|
J. Craig Venter Institute Researchers Publish Significant Advance In Genome Assembly Technology [NEWS] Advance Allows for More Efficient Construction of Synthetic Genomes ROCKVILLE, Md., Dec. 4 /PRNewswire-USNewswire/ — Researchers at the J. Craig Venter Institute (JCVI), a not-for-profit genomic research organization, have published a paper describing a significant advance in genome assembly in which the team can now assemble the whole bacterial genome, Mycoplasma genital... |
|
ISTA Pharmaceuticals Announces Phase III Results For Once-Daily Topical Xibrom(TM) 0.09% [NEWS] IRVINE, Calif., Dec. 4 /PRNewswire-FirstCall/ — ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), an ophthalmic pharmaceutical company, today announced results from the Company's recently completed Phase III clinical program of Xibrom™ (0.09% bromfenac sodium ophthalmic solution) QD (once-daily). The program enrolled 282 patients who underwent cataract surgery in two U.S. multi-... |
|
Two-Year Follow-Up Data Demonstrates Preservation Of Adequate Mitral Valve Area In Patients ... [NEWS] MENLO PARK, Calif., Dec. 4 /PRNewswire/ — Long-term data published in EuroIntervention showed that the expected decrease in Mitral Vale Area (MVA) after repair with the MitraClip® system to correct mitral regurgitation (MR) is not associated with clinically significant mitral stenosis. Additionally, with two years of follow-up, none of the patients treated with the MitraClip... |
|
GEN Reports Growing Focus On PI3-Kinase Pathway In Cancer Research [NEWS] NEW ROCHELLE, N.Y., Dec. 4 /PRNewswire/ — Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN). The pathway is involved in angiogenesis, cell growth, differentiation, and survival. In additio... |
|
Bone Marrow-Derived Stem Cells May Offer Novel Therapeutic Option For Skin Disorder [NEWS] WASHINGTON, Dec. 4 — Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study pre-published online in Blood, the official journal of the American Society of Hematology. Epidermolysis bullosa is a disorder characterized by ... |
|
Transgenomic Obtains Exclusive License To Mitochondrial DNA Damage Detection Technology [NEWS] OMAHA, Neb., Dec. 4 — Transgenomic (OTC Bulletin Board: TBIO) today announced that the Clayton Foundation for Research of Houston, Texas through its technology transfer entity, the Research Development Foundation, has granted the Company an exclusive license to patents covering a method for mitochondrial DNA (mtDNA) damage detection. The patents form the basis for the development of ... |
|
NeoStem's New York City Adult Stem Cell Collection Center Has Opened And Begun Collections [NEWS] NEW YORK, Dec. 4 /PRNewswire-FirstCall/ — NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that it has reached a major milestone in its current business plan with the opening of the first ever collection center for collection of adult stem cells by the ... |
|
MedImmune Advances Asthma Program With Start Of Phase 2 Clinical Trial For Antibody Targeting ... [NEWS] GAITHERSBURG, Md., Dec. 4 — MedImmune today announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that targets the interleukin-5 receptor (IL-5R). Preclinical data suggest that inhibiting the IL-5R pathway may lead to a targeted approach for treating patients wit... |
|
'Friendly Bacteria Improve Health' Segment Broadcasts On The National Medical Report [NEWS] - Millions of Americans will be able to learn about the health benefits of probiotics on public television - TORRANCE, Calif., Dec. 4 — Yakult USA Inc., the North American business of global leader and probiotics pioneer, Yakult Honsha Co., Ltd., is pleased to announce that it will broadcast an educational segment entitled “Friendly bacteri... |
|
Senior Clinical Project Manager [JOB] The Execu-Search Group, New York , New York , United States A growing, publicly traded medical product development group is seeking two Senior Clinical Project Managers for immediate consideration.... |
|
Sr. Director/Exec Dir Of Drug Safety/Pharmacovigilance [JOB] The Execu-Search Group, New York, New York, United States As Senior Director of Drug Safety, you will have a variety of responsibilities integral to the success of your team and your company.... |
|
Early Career Scientists And Engineers: Computational Biochemistry Research Group [JOB] D. E. Shaw Research, New York, New York, United States D. E. Shaw Research (“DESRES”) is an independent research laboratory that conducts basic scientific research in the field of computational biochemistry under the direct scientific leadership of Dr. David Shaw, who serves as its Chief Scientist.... |
|
Clinical Pharmacokineticist [JOB] Drug development biotechnology company in Boston, Boston, MA, USA... |
|
Study Director Toxicology [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
Chemistry Study Director [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
Quality Assurance Monitor-Microbiology [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
Medical Technologist Job Description [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
Director Of Safety Pharmacology [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
Quality Assurance Manager [JOB] Toxikon Corporation, Bedford, MA, USA... |
|
GEOSTATS 2008--VIII INTERNATIONAL GEOSTATISTICS CONGRESS [EVENT] December 1 - 5, 2008 in Santiago, Chile... |
|
2008 Material Research Society Fall Meeting [EVENT] December 1 - 5, 2008 in Boston, MA , UNITED STATES... |
|
NZTHRC - New Zealand Tourism And Hospitality Research Conference [EVENT] December 3 - 5, 2008 in Hanmer Springs, Canterbury, New Zealand... |
|
Peripheral Vision [EVENT] December 3 - 5, 2008 in Wellington, New Zealand... |
|
Safety Change Agents Masterclass [EVENT] December 3 - 5, 2008 in Melbourne, VIC, Australia... |
| Related Feeds |
| >> caostheory at Yahoo! Groups |
| >> International Immunology - current issue |
| >> Physics Help and Math Help - Physics Forums |
| >> ReviseMRI.com?Latest Additions |
| Other Feeds |